Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss Dole Q1 2026 Earnings EPS Misses Expectations by 34 Shares Edge Lower CNM Q1 2026 Earnings Earnings Beat Driven by Strong Demand and Operational Efficiency OXM Q1 2026 Earnings A Significant Earnings Miss Amid Strategic Adjustments SABS Q1 2026 Earnings EPS Misses Estimates Stock Rises on Pipeline Progress ClearPoint Neuro Inc CLPT Q1 2026 Earnings EPS Misses Estimates by 1478 Amid Operational Investment